Press Releases

LIQUID STABLE ENZYME ER™ CALIBRATION VERIFIER KIT AVAILABLE FROM VERICHEM LABORATORIES

VERICHEM LABORATORIES is pleased to announce the availability of their ready-to-use, liquid stable ENZYME ER™ Verifier Kit, expressly designed for the calibration verification of enzyme assays on any “wet” clinical testing system.

Independent Site Management Organisation Panthera prepares for COVID-19

Independent Site Management Organisation Panthera is working with sponsors who need to press ahead with trials which can be done safely.

COVID-19 Antibody Test Released by Ortho Clinical Diagnostics

Scopio Labs Receives CE Mark for X100 Microscope and Decision Support System With Full Field Peripheral Blood Smear (PBS) Application

Scopio Labs Receives CE Mark for X100 Microscope and Decision Support System With Full Field Peripheral Blood Smear (PBS) Application

Clinically-proven gamification app teaches positive inhaler technique; crucial for managing asthma

A newly validated app called Rafi-Tone, developed by clinicians in the UK, makes using an inhaler with a spacer easier and more fun for young children with wheeze or asthma symptoms.

Biological Specialty Company Launches At-home Blood Donation Service for COVID-19 Patients Who Want to Help Develop New Drugs and Vaccines

BSC is collecting blood samples from sick and recovered COVID-19 patients to assist in developing COVID-19 therapies, vaccines and diagnostic biomarkers.

Ortho’s Total Antibody Test for COVID-19 Receives Emergency Use Authorization from FDA

FLUXERGY SUBMITS REQUEST FOR FDA EMERGENCY USE AUTHORIZATION (EUA) FOR ONE-HOUR COVID-19 TEST AT POINT-OF-CARE EUA Application Follows Completion of Test Validation with Patient Samples by Physician-Scientists at UC San Diego

Fluxergy LLC has filed an Emergency Use Authorization (EUA) request for FDA authorization of the company's high-speech COVID-19 diagnostic test, which has been shown to provide sample-to-answer data within one hour at the point-of-care.

CD Bioparticles Announces Carbon-based Nanocages Production Services for Researchers

CD Bioparticles introduces carbon-based nanocages production services to global researchers.

CDx Diagnostics Announces Contract with Blue Cross Blue Shield of Massachusetts for WATS3D Biopsy

MicroGenDX Offers 24-hour COVID-19 Saliva Test to Overcome Supply Shortage Issues

The FDA has provided Emergency Use Authorization for a new 24-hour, Saliva Test for COVID-19, available now to clinics, hospitals and patients. This will alleviate resource shortages (swabs and transport) hindering other testing methods. MicroGenDX is ramping up capacity for 10,000 tests/day with a turnaround time of 24 hours.

Wolters Kluwer Arms Coronavirus Efforts with New Global Interactive Map using UpToDate

DermTech Announces Response to COVID-19

WCG Launches Program to Provide Clinical Research Professionals with Timely Information During the COVID-19 Pandemic

The initiative launches with a weekly webinar series featuring WCG experts and guest panelists, with a focus on communicating emerging best practices in real time.

Creative Bioarray Introduces Advanced In Vitro Neurotoxicity Assay

With years of exploration in neurotoxicity, Creative Bioarray releases in vitro neurotoxicity assays, including high throughput microelectrode array and neurite outgrowth assay, to figure out the effects of chemicals on the morphology and electrophysiological activity of neurons.

Creative Biogene Unveils Its Wide-ranging CRISPR Library Screening Services

Creative Biogene CRISPR/Cas9 Platform provides comprehensive CRISPR library screening services, which significantly assists customers in drug development by offering high-quality and high-confidence results.

New Studies Find Bio-Rad’s QX200 Droplet Digital PCR System Can Detect COVID-19 With Greater Sensitivity and Precision Than Other Existing Molecular Tests

Bio-Rad Laboratories, Inc. announced that in two studies published this month, ahead of peer-review, researchers in China reported that Bio-Rad’s QX200 Droplet Digital PCR (ddPCR) System showed superior sensitivity and precision for clinical detection of SARS-CoV-2 (the virus that causes COVID-19) compared to existing test methods that are performed using qPCR.

LIQUID STABLE, BILIRUBIN REFERENCE STANDARDS NOW AVAILABLE FROM VERICHEM LABORATORIES

VERICHEM LABORATORIES offers a line of liquid stable, protein based, bilirubin reference materials specifically designed and intended for CLIA calibration verification of total and direct bilirubin assays with any wet chemistry, clinical testing systems.

AusDiagnostics SARS-CoV-2 panel now included in the Australian Register of Therapeutic Goods and receives CE marking

AusDiagnostics has included its dual target SARS-CoV-2, Influenza and RSV panel in the Australian Register of Therapeutic Goods. It has also been CE marked.

Creative Diagnostics Now Launches New Plant Pathogens Antibodies for Research Use

Creative Diagnostics launches plant pathogens antibodies for use in ELISA or related immunoassays.